These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 8632302)
1. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist. Zocchi C; Ongini E; Conti A; Monopoli A; Negretti A; Baraldi PG; Dionisotti S J Pharmacol Exp Ther; 1996 Feb; 276(2):398-404. PubMed ID: 8632302 [TBL] [Abstract][Full Text] [Related]
2. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261. Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373 [TBL] [Abstract][Full Text] [Related]
3. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists. Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infantas y Villatoro MJ; Zocchi C; Dionisotti S; Ongini E J Med Chem; 1996 Mar; 39(5):1164-71. PubMed ID: 8676354 [TBL] [Abstract][Full Text] [Related]
4. Characterization of 8-(N-methylisopropyl)amino-N6-(5'-endohydroxy- endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine antagonist of A1 adenosine receptors. Martin PL; Wysocki RJ; Barrett RJ; May JM; Linden J J Pharmacol Exp Ther; 1996 Feb; 276(2):490-9. PubMed ID: 8632314 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the rat. Monopoli A; Casati C; Lozza G; Forlani A; Ongini E J Pharmacol Exp Ther; 1998 Apr; 285(1):9-15. PubMed ID: 9535988 [TBL] [Abstract][Full Text] [Related]
6. Pharmacology of the new selective A2a adenosine receptor agonist 2-hexynyl-5'-N-ethylcarboxamidoadenosine. Monopoli A; Conti A; Zocchi C; Casati C; Volpini R; Cristalli G; Ongini E Arzneimittelforschung; 1994 Dec; 44(12):1296-304. PubMed ID: 7848347 [TBL] [Abstract][Full Text] [Related]
7. Labeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261. Dionisotti S; Ferrara S; Molta C; Zocchi C; Ongini E J Pharmacol Exp Ther; 1996 Sep; 278(3):1209-14. PubMed ID: 8819504 [TBL] [Abstract][Full Text] [Related]
8. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes. Zocchi C; Ongini E; Ferrara S; Baraldi PG; Dionisotti S Br J Pharmacol; 1996 Apr; 117(7):1381-6. PubMed ID: 8730729 [TBL] [Abstract][Full Text] [Related]
9. [3H]-SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes. Varani K; Gessi S; Dionisotti S; Ongini E; Borea PA Br J Pharmacol; 1998 Apr; 123(8):1723-31. PubMed ID: 9605581 [TBL] [Abstract][Full Text] [Related]
10. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig. Haynes JM; Alexander SP; Hill SJ Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342 [TBL] [Abstract][Full Text] [Related]
11. 1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells. Belardinelli L; Shryock JC; Zhang Y; Scammells PJ; Olsson R; Dennis D; Milner P; Pfister J; Baker SP J Pharmacol Exp Ther; 1995 Dec; 275(3):1167-76. PubMed ID: 8531078 [TBL] [Abstract][Full Text] [Related]
12. Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]-SCH 58261 binding. Varani K; Gessi S; Dalpiaz A; Ongini E; Borea PA Br J Pharmacol; 1997 Sep; 122(2):386-92. PubMed ID: 9313951 [TBL] [Abstract][Full Text] [Related]
13. Adenosine receptors involved in modulation of noradrenaline release in isolated rat tail artery. Diniz C; Fresco P; Leal S; Gonçalves J Eur J Pharmacol; 2004 Nov; 504(1-2):17-25. PubMed ID: 15507216 [TBL] [Abstract][Full Text] [Related]
14. Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats. Pinna A; Fenu S; Morelli M Synapse; 2001 Mar; 39(3):233-8. PubMed ID: 11284438 [TBL] [Abstract][Full Text] [Related]
15. Effects of the new A2 adenosine receptor antagonist 8FB-PTP, an 8 substituted pyrazolo-triazolo-pyrimidine, on in vitro functional models. Dionisotti S; Conti A; Sandoli D; Zocchi C; Gatta F; Ongini E Br J Pharmacol; 1994 Jun; 112(2):659-65. PubMed ID: 8075885 [TBL] [Abstract][Full Text] [Related]
16. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig. Martin PL; Ueeda M; Olsson RA J Pharmacol Exp Ther; 1993 Apr; 265(1):248-53. PubMed ID: 8474010 [TBL] [Abstract][Full Text] [Related]
17. Study of the novel non-xanthine heterocyclic compound GU285 as a potent non-selective adenosine receptor antagonist in the rat. Harden FA; Brown L; Quinn RJ; Harrison GJ; Headrick JP; Rose'Meyer RB; Willis RJ Arzneimittelforschung; 2002; 52(3):175-81. PubMed ID: 11963644 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists. Baraldi PG; Cacciari B; Spalluto G; Bergonzoni M; Dionisotti S; Ongini E; Varani K; Borea PA J Med Chem; 1998 Jun; 41(12):2126-33. PubMed ID: 9622554 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists. Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033 [TBL] [Abstract][Full Text] [Related]
20. ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus. Cunha RA; Constantino MD; Ribeiro JA Br J Pharmacol; 1997 Dec; 122(7):1279-84. PubMed ID: 9421273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]